[PDF] EAU Guidelines on Testicular Cancer



Previous PDF Next PDF


















[PDF] eau ionisée danger

[PDF] une demi bouteille de vin par jour

[PDF] 3 verres de vin par jour alcoolique

[PDF] 2 grammes d'alcool dans le sang combien de verres

[PDF] 2 verres de vin par jour alcoolique

[PDF] combien de verre de vin par jour

[PDF] unité d'alcool en gramme dans le sang

[PDF] unité d'alcool conduite

[PDF] andreas moritz pdf

[PDF] cure du foie moritz danger

[PDF] nettoyage foie danger

[PDF] nettoyage du foie effets secondaires

[PDF] l'étonnant nettoyage du foie et de la vésicule bil

[PDF] andreas moritz livre

[PDF] nettoyage foie jus de pomme

EAU Guidelines on Testicular Cancer

M.P. Laguna (Chair), P. Albers, F. Algaba,

C.

Bokemeyer, J.L. Boormans,

D. di Nardo (Patient advocate), S. Fischer,

K. Fizazi, H. Gremmels (Patient advocate), R. Leão,

D. Nicol, N. Nicolai, J. Oldenburg, T. Tandstad

Guidelines Associates

: J. Mayor de Castro, C.D. Fankhauser,

F. Janisch, T. Muilwijk

Consultant radiologist

: Y. Jain

Guidelines Office

: R. Shepherd© European Association of Urology 2022

Testicular

Cancer

EAU Guidelines on

TESTICULAR CANCER - LIMITED UPDATE MARCH 20222

TABLE OF CONTENTS

PAGE 1.

INTRODUCTION

5

1.1 Aim and objectives 5

1.2 Panel composition 5

1.3 Available publications 5

1.4 Publication history and summary of changes 5

1.4.1 Publication history 5

1.4.2 Summary of changes 5

2.

METHODS 5

2.1 Review 6

2.2 Future goals 6

3.

EPIDEMIOLOGY, AETIOLOGY & PATHOLOGY 6

3.1 Epidemiology and Aetiology 6

3.2 Histological classification 7

4.

STAGING & CLASSIFICATION SYSTEMS 8

4.1 Staging 8

4.2 The Union for International Cancer Control prognostic groups 9

4.3 The International Germ Cell Cancer Collaborative classification for the prognostic-risk

groups of metastatic testicular cancer 10 5.

DIAGNOSTIC EVALUATION 11

5.1 Physical examination 11

5.2 Imaging 11

5.2.1 Ultrasonography of the testes 11

5.2.2 Computerised tomography 11

5.2.3 Magnetic resonance imaging 12

5.2.4 Fluorodeoxyglucose-positron emission tomography 12

5.2.5 Bone scan 12

5.3 Serum tumour markers 12

5.3.1 Pre-operative serum tumour markers 12

5.3.2 Serum tumour markers after orchidectomy 12

5.3.3 Other tumour markers 13

5.4 Inguinal exploration and initial management 13

5.4.1 Orchidectomy 13

5.4.2 Testis-sparing surgery 13

5.4.3 Insertion of testicular prosthesis 13

5.4.4 Contralateral biopsy 13

5.5 Pathological examination of the testis 14

5.6 Screening 16

5.7 Impact on fertility and fertility-associated issues 16

5.8 Guidelines for the diagnosis and staging of Testicular Cancer 17

6.

PROGNOSIS 18

6.1 Risk factors for metastatic relapse in clinical stage I testicular cancer 18

7.

DISEASE MANAGEMENT 18

7.1 Stage I germ cell tumours 18

7.1.1 Germ cell neoplasia “in situ" (GCNIS) 18

7.1.2 Seminoma germ cell tumour clinical stage I (SGCT CS I) 19

7.1.2.1 Surveillance 19

7.1.2.2 Adjuvant chemotherapy 19

7.1.2.3 Adjuvant radiotherapy 19

7.1.2.4 Risk-adapted treatment 19

7.1.2.5 Guidelines for the treatment of clinical stage I seminoma testis

tumours 20

3TESTICULAR CANCER - LIMITED UPDATE MARCH 2022

quotesdbs_dbs2.pdfusesText_2